SPRB
SPRUCE BIOSCIENCES, INC.
Company overview
- Market capitalization
- $136.54M
- Employees
- 8
- Latest publication
- 2026-09-29
About SPRUCE BIOSCIENCES, INC.
Spruce Biosciences, Inc. is a biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders. The company develops TA-ERT, a fusion protein comprised of recombinant human alpha-N-acetylglucosaminidase, which is an enzyme replacement therapy for patients with Sanfilippo Syndrome Type B. It also develops Tildacerfont for treating a highly debilitating mental disorder characterized by depressed mood with cognitive-affective and somatic changes, including anhedonia, weight alterations, and altered sleeping patterns. In addition, the company develops SPR202 for the treatment of Congenital Adrenal Hyperplasia (CAH), a chronic and potentially life-threatening rare disease with no cure. The company has a license agreement with Eli Lilly and Company to research, develop, and commercialize various pharmaceutical compounds. It also has a collaboration and license agreement with Kaken Pharmaceutical Co. Ltd. to develop, manufacture, and commercialize Tildacerfont for the treatment of CAH in Japan. Spruce Biosciences, Inc. was incorporated in 2014 and is headquartered in South San Francisco, California.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 697,000USD | 697,000USD | 602,000USD | 1,610,000USD |
| Research Development | 7,575,000USD | 4,104,000USD | 5,011,000USD | 430,000USD | 10,837,000USD | 21,457,000USD | 6,554,000USD | 8,090,000USD |
| Selling General Administrative | 4,412,000USD | 6,996,000USD | 3,218,000USD | 3,122,000USD | 3,655,000USD | 3,314,000USD | 3,456,000USD | 3,556,000USD |
| Total Operating Expenses | 11,987,000USD | 11,100,000USD | 8,229,000USD | 2,692,000USD | 14,492,000USD | 24,771,000USD | 10,010,000USD | 11,646,000USD |
| Operating Income | -11,987,000USD | -11,100,000USD | -8,229,000USD | -2,692,000USD | -14,492,000USD | -24,074,000USD | -9,408,000USD | -10,036,000USD |
| Interest Income | 486,000USD | 40,000USD | 36,000USD | 654,000USD | 487,000USD | 571,000USD | 808,000USD | 938,000USD |
| Interest Expense | 674,000USD | 6,000USD | 19,000USD | 29,000USD | 36,000USD | 56,000USD | 71,000USD | 83,000USD |
| Net Interest Income | -188,000USD | -46,000USD | 17,000USD | 625,000USD | 451,000USD | 515,000USD | 737,000USD | 855,000USD |
| Income Before Tax | -12,266,000USD | -14,646,000USD | -8,212,000USD | -2,067,000USD | -14,041,000USD | -23,559,000USD | -8,671,000USD | -9,181,000USD |
| Net Income | -12,266,000USD | -14,646,000USD | -8,212,000USD | -2,067,000USD | -14,041,000USD | -23,559,000USD | -8,671,000USD | -9,181,000USD |
| Net Income From Continuing Ops | -12,266,000USD | -14,646,000USD | -8,212,000USD | -2,067,000USD | -14,041,000USD | -23,559,000USD | -8,671,000USD | -9,181,000USD |
| Ebitda | -11,987,000USD | -14,635,000USD | -8,190,000USD | -2,031,000USD | -13,999,000USD | — | -8,590,000USD | -9,086,000USD |
| Reconciled Depreciation | 252,000USD | 5,000USD | 3,000USD | 7,000USD | 6,000USD | 9,000USD | 10,000USD | 12,000USD |
| Total Other Income Expense Net | -279,000USD | -3,546,000USD | 17,000USD | 625,000USD | 451,000USD | — | 737,000USD | 855,000USD |
| Cost Of Revenue | — | 5,000USD | — | — | — | — | — | 8,090,000USD |
| Gross Profit | — | -5,000USD | — | — | 697,000USD | — | 602,000USD | 1,610,000USD |
| Ebit | — | -14,640,000USD | -8,193,000USD | -2,038,000USD | -14,005,000USD | — | -8,600,000USD | -9,098,000USD |
| Depreciation And Amortization | — | 5,000USD | 3,000USD | 7,000USD | 6,000USD | — | 10,000USD | 12,000USD |
| Selling And Marketing Expenses | — | — | — | — | — | — | — | 12,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 4,911,000USD | 10,089,000USD | 1,964,000USD | 0USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 21,000USD | — | 49,432,000USD | 429,000USD | 381,000USD | 102,000USD | 12,000USD | 1,000USD |
| Gross Profit | -21,000USD | 4,911,000USD | 10,089,000USD | -429,000USD | -381,000USD | -102,000USD | -12,000USD | -1,000USD |
| Research Development | 19,522,000USD | 46,418,000USD | 49,432,000USD | 35,198,000USD | 30,698,000USD | 23,854,000USD | 10,817,000USD | 8,403,000USD |
| Selling General Administrative | 16,991,000USD | 14,644,000USD | 12,650,000USD | 12,085,000USD | 11,368,000USD | 5,562,000USD | 2,290,000USD | 1,569,000USD |
| Total Operating Expenses | 36,513,000USD | 61,062,000USD | 62,082,000USD | 47,283,000USD | 42,066,000USD | 29,416,000USD | 13,107,000USD | 9,972,000USD |
| Operating Income | -36,513,000USD | -56,151,000USD | -51,993,000USD | -47,283,000USD | -42,066,000USD | -29,416,000USD | -13,107,000USD | -9,972,000USD |
| Interest Income | 1,137,000USD | 3,422,000USD | 4,332,000USD | 1,523,000USD | 119,000USD | — | — | — |
| Interest Expense | 90,000USD | 307,000USD | 483,000USD | 420,000USD | 345,000USD | 323,000USD | 65,000USD | 0USD |
| Net Interest Income | 1,047,000USD | 3,115,000USD | 3,826,000USD | 1,103,000USD | -345,000USD | -323,000USD | -65,000USD | 0USD |
| Income Before Tax | -38,966,000USD | -53,036,000USD | -47,919,000USD | -46,180,000USD | -42,292,000USD | -29,539,000USD | -13,088,000USD | -9,858,000USD |
| Net Income | -38,966,000USD | -53,036,000USD | -47,919,000USD | -46,180,000USD | -42,292,000USD | -29,539,000USD | -13,237,000USD | -9,858,000USD |
| Net Income From Continuing Ops | -38,966,000USD | -53,036,000USD | -49,113,000USD | -46,180,000USD | -42,292,000USD | -29,539,000USD | -13,088,000USD | -9,858,000USD |
| Ebit | -38,876,000USD | -52,729,000USD | -47,436,000USD | -45,760,000USD | -41,947,000USD | -29,416,000USD | -13,023,000USD | -9,972,000USD |
| Ebitda | -38,855,000USD | -52,683,000USD | -47,366,000USD | -45,686,000USD | -41,879,000USD | -29,380,000USD | -13,011,000USD | -9,971,000USD |
| Depreciation And Amortization | 21,000USD | 46,000USD | 70,000USD | 74,000USD | 68,000USD | 36,000USD | 12,000USD | 1,000USD |
| Reconciled Depreciation | 21,000USD | 46,000USD | 78,000USD | 74,000USD | 68,000USD | 36,000USD | 12,000USD | 1,000USD |
| Total Other Income Expense Net | -2,453,000USD | 3,115,000USD | 4,074,000USD | 1,103,000USD | -226,000USD | -123,000USD | 19,000USD | 114,000USD |
| Selling And Marketing Expenses | — | — | 70,000USD | — | — | — | — | — |
| Income Tax Expense | — | — | -97,895USD | -1,103,000USD | 396,000USD | 487,000USD | 149,000USD | 114,000USD |
| Non Operating Income Net Other | — | — | — | 1,523,000USD | — | 200,000USD | — | — |
| Net Income Applicable To Common Shares | — | — | — | -46,180,000USD | -42,292,000USD | -29,539,000USD | -13,088,000USD | -9,858,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 102,852,000USD | 56,166,000USD | 53,021,000USD | 15,313,000USD | 21,820,000USD | 31,649,000USD | 45,209,000USD | 65,102,000USD |
| Cash And Equivalents | 96,295,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 101,154,000USD | 55,032,000USD | 52,112,000USD | 14,516,000USD | 20,953,000USD | 30,576,000USD | 44,206,000USD | 63,573,000USD |
| Other Current Assets | 234,000USD | 952,000USD | 3,206,000USD | 3,847,000USD | 4,566,000USD | 4,961,000USD | 2,276,000USD | 3,518,000USD |
| Other Non Current Assets | 1,175,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 19,122,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 10,963,000USD | 11,784,000USD | 10,086,000USD | 9,427,000USD | 8,060,000USD | 15,666,000USD | 15,246,000USD | 11,858,000USD |
| Other Current Liabilities | 7,254,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 83,730,000USD | 34,648,000USD | 42,516,000USD | 5,386,000USD | 13,180,000USD | 15,324,000USD | 28,821,000USD | 51,638,000USD |
| Total Equity Including Noncontrolling Interest | 83,730,000USD | — | — | — | — | — | — | — |
| Short Long Term Debt | 2,500,000USD | 1,000,000USD | — | 539,000USD | 943,000USD | 1,345,000USD | 1,622,000USD | 1,622,000USD |
| Long Term Debt | 4,591,000USD | 5,464,000USD | — | — | — | — | 124,000USD | 524,000USD |
| Accounts Payable | 1,209,000USD | 2,683,000USD | 943,000USD | 1,386,000USD | 807,000USD | 1,879,000USD | 1,295,000USD | 1,799,000USD |
| Common Stock | 0USD | — | — | — | — | 4,000USD | — | 4,000USD |
| Retained Earnings | -317,729,000USD | -301,500,000USD | -289,234,000USD | -274,588,000USD | -266,376,000USD | -264,309,000USD | -250,268,000USD | -226,709,000USD |
| Total Liab | — | 21,518,000USD | 10,505,000USD | 9,927,000USD | 8,640,000USD | 16,325,000USD | 16,388,000USD | 13,464,000USD |
| Other Current Liab | — | 7,775,000USD | 8,826,000USD | 7,193,000USD | 6,010,000USD | 12,151,000USD | — | 7,465,000USD |
| Capital Stock | — | 0USD | 0USD | 0USD | 0USD | 4,000USD | 0USD | 4,000USD |
| Cash | — | 54,080,000USD | 48,906,000USD | 10,669,000USD | 16,387,000USD | 25,615,000USD | 38,753,000USD | 60,055,000USD |
| Cash And Short Term Investments | — | 54,080,000USD | 48,906,000USD | 10,669,000USD | 16,387,000USD | 25,615,000USD | — | 60,055,000USD |
| Net Debt | — | -46,958,000USD | -48,170,000USD | -9,321,000USD | -14,564,000USD | -23,320,000USD | — | -56,825,000USD |
| Short Term Debt | — | 1,326,000USD | 317,000USD | 848,000USD | 1,243,000USD | 1,636,000USD | — | 1,897,000USD |
| Short Long Term Debt Total | — | 7,122,000USD | 736,000USD | 1,348,000USD | 1,823,000USD | 2,295,000USD | — | 3,230,000USD |
| Property Plant Equipment Net | — | 595,000USD | 666,000USD | 735,000USD | 803,000USD | 869,000USD | 934,000USD | 998,000USD |
| Property Plant Equipment Gross | — | 595,000USD | 666,000USD | 735,000USD | 803,000USD | 869,000USD | 934,000USD | 998,000USD |
| Common Stock Shares Outstanding | — | 1,372,084shares | 766,598shares | 563,066shares | 606,294shares | 571,284shares | 563,083shares | 536,933shares |
| Non Current Assets Total | — | 1,134,000USD | 909,000USD | 797,000USD | 867,000USD | 1,073,000USD | 1,003,000USD | 1,529,000USD |
| Non Current Liabilities Total | — | 9,734,000USD | 419,000USD | 500,000USD | 580,000USD | 659,000USD | 1,142,000USD | 1,606,000USD |
| Non Currrent Assets Other | — | 503,000USD | 207,000USD | 27,000USD | 64,000USD | 204,000USD | 69,000USD | 531,000USD |
| Net Working Capital | — | 43,248,000USD | 42,026,000USD | 5,089,000USD | 12,893,000USD | 14,910,000USD | 28,960,000USD | 51,715,000USD |
| Unclassified Non Current Liabilities | — | 4,270,000USD | — | — | — | — | — | — |
| Unclassified Equity | — | 336,148,000USD | 331,750,000USD | 279,974,000USD | 279,556,000USD | 279,625,000USD | 279,089,000USD | 278,339,000USD |
| Unclassified Current Liabilities | — | — | — | — | — | -1,345,000USD | 12,329,000USD | -1,622,000USD |
| Non Current Liabilities Other | — | — | — | — | — | — | 282,000USD | 273,000USD |
| Unclassified Current Assets | — | — | — | — | — | — | 3,177,000USD | — |
| Current Deferred Revenue | — | — | — | — | — | — | — | 697,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 53,021,000USD | 45,209,000USD | 103,946,000USD | 85,648,000USD | 126,486,000USD | 162,883,000USD | 4,692,000USD | 4,775,000USD |
| Other Current Assets | 3,206,000USD | 5,453,000USD | 5,844,000USD | 4,531,000USD | 2,926,000USD | 3,247,000USD | 728,000USD | 661,000USD |
| Total Liab | 10,505,000USD | 16,388,000USD | 27,437,000USD | 17,162,000USD | 15,115,000USD | 13,456,000USD | 35,329,000USD | 22,577,000USD |
| Total Stockholder Equity | 42,516,000USD | 28,821,000USD | 76,509,000USD | 68,486,000USD | 111,371,000USD | 149,427,000USD | -30,637,000USD | -17,802,000USD |
| Other Current Liab | 8,826,000USD | 12,046,000USD | 14,349,000USD | 9,260,000USD | 5,688,000USD | 3,332,000USD | 1,173,000USD | 405,000USD |
| Capital Stock | 0USD | 4,000USD | 4,000USD | 3,000USD | 3,000USD | 2,000USD | 1,000USD | 1,000USD |
| Retained Earnings | -289,234,000USD | -250,268,000USD | -197,232,000USD | -149,313,000USD | -103,133,000USD | -60,841,000USD | -31,302,000USD | -18,214,000USD |
| Cash | 48,906,000USD | 38,753,000USD | 96,339,000USD | 24,487,000USD | 42,748,000USD | 157,150,000USD | 3,924,000USD | 4,112,000USD |
| Cash And Short Term Investments | 48,906,000USD | 38,753,000USD | 96,339,000USD | 79,077,000USD | 88,969,000USD | 157,150,000USD | 3,924,000USD | 4,112,000USD |
| Total Current Assets | 52,112,000USD | 44,206,000USD | 102,183,000USD | 83,608,000USD | 91,895,000USD | 160,397,000USD | 4,652,000USD | 4,773,000USD |
| Total Current Liabilities | 10,086,000USD | 15,246,000USD | 24,465,000USD | 12,447,000USD | 8,871,000USD | 9,763,000USD | 4,303,000USD | 2,705,000USD |
| Net Debt | -48,170,000USD | -35,988,000USD | -91,730,000USD | -18,172,000USD | -36,217,000USD | -150,772,000USD | 521,000USD | -4,112,000USD |
| Short Term Debt | 317,000USD | 1,905,000USD | 1,873,000USD | 1,761,000USD | 360,000USD | 2,803,000USD | 1,252,000USD | — |
| Short Long Term Debt Total | 736,000USD | 2,765,000USD | 4,609,000USD | 6,315,000USD | 6,531,000USD | 6,378,000USD | 4,445,000USD | — |
| Accounts Payable | 943,000USD | 1,295,000USD | 3,332,000USD | 1,426,000USD | 2,823,000USD | 3,628,000USD | 1,878,000USD | 2,300,000USD |
| Property Plant Equipment Net | 666,000USD | 934,000USD | 1,181,000USD | 1,400,000USD | 1,479,000USD | 1,866,000USD | — | — |
| Property Plant Equipment Gross | 666,000USD | 934,000USD | 1,181,000USD | 1,400,000USD | 1,479,000USD | 1,793,000USD | — | — |
| Common Stock Shares Outstanding | 766,598shares | 536,444shares | 500,633shares | 611,705shares | 607,397shares | 604,770shares | 578,853shares | 19,875shares |
| Non Current Assets Total | 909,000USD | 1,003,000USD | 1,763,000USD | 2,040,000USD | 34,591,000USD | 2,486,000USD | 40,000USD | 2,000USD |
| Non Current Liabilities Total | 419,000USD | 1,142,000USD | 2,972,000USD | 4,715,000USD | 6,244,000USD | 3,693,000USD | 31,026,000USD | 19,872,000USD |
| Non Currrent Assets Other | 243,000USD | 69,000USD | 582,000USD | 55,175,410USD | 653,000USD | 620,000USD | 40,000USD | 2,000USD |
| Net Working Capital | 42,026,000USD | 28,960,000USD | 77,718,000USD | 71,161,000USD | 83,024,000USD | 150,634,000USD | 349,000USD | 2,068,000USD |
| Unclassified Equity | 331,750,000USD | 279,081,000USD | 273,733,000USD | 218,351,000USD | 214,682,000USD | 210,264,000USD | 28,476,000USD | — |
| Common Stock | — | 4,000USD | 4,000USD | 3,000USD | 3,000USD | 2,000USD | 1,000USD | 1,000USD |
| Short Long Term Debt | — | 1,622,000USD | 1,622,000USD | 1,622,000USD | — | 2,554,000USD | 1,252,000USD | — |
| Long Term Debt | — | 124,000USD | 1,717,000USD | 3,293,000USD | 4,878,000USD | 1,922,000USD | 3,193,000USD | — |
| Non Current Liabilities Other | — | 282,000USD | 236,000USD | 1,422,000USD | 73,000USD | 118,000USD | 20,000USD | — |
| Unclassified Current Liabilities | — | -1,622,000USD | -1,622,000USD | -1,622,000USD | — | -2,554,000USD | -1,252,000USD | — |
| Other Assets | — | — | 1USD | 640,000USD | 513,000USD | 2,486USD | 40,000USD | 2,000USD |
| Current Deferred Revenue | — | — | 4,911,000USD | — | — | — | — | — |
| Short Term Investments | — | — | 0USD | 54,590,000USD | 46,221,000USD | 0USD | — | — |
| Accumulated Other Comprehensive Income | — | — | 0USD | -558,000USD | -184,000USD | 0USD | -27,813,000USD | 0USD |
| Unclassified Non Current Liabilities | — | — | 1,019,000USD | — | 1,220,000USD | 1,535,000USD | 27,793,000USD | 19,872,000USD |
| Other Liab | — | — | — | 161,000USD | 73,000USD | 118,000USD | 20,000USD | — |
| Long Term Investments | — | — | — | 0USD | 32,459,000USD | 0USD | — | — |
| Net Tangible Assets | — | — | — | 68,486,000USD | 111,371,000USD | 149,427,000USD | -30,637,000USD | -17,802,000USD |
| Unclassified Non Current Assets | — | — | — | -55,175,410USD | — | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -12,266,000USD | -14,646,000USD | -8,212,000USD | -2,067,000USD | -14,041,000USD | -23,559,000USD | -8,671,000USD | -9,181,000USD |
| Depreciation | 252,000USD | 5,000USD | 3,000USD | 7,000USD | 6,000USD | 9,000USD | 10,000USD | 12,000USD |
| Stock Based Compensation | 689,000USD | 1,692,000USD | 415,000USD | -77,000USD | 544,000USD | 961,000USD | 1,140,000USD | 1,685,000USD |
| Other Non Cash Items | 1,103,000USD | 4,086,000USD | 170,000USD | -395,000USD | -93,000USD | 64,000USD | 62,000USD | 63,000USD |
| Change In Working Capital | 2,431,000USD | 2,407,000USD | 2,308,000USD | -6,296,000USD | 857,000USD | 1,848,000USD | -1,764,000USD | -3,685,000USD |
| Total Cash From Operating Activities | -8,732,000USD | -6,456,000USD | -5,316,000USD | -8,828,000USD | -12,727,000USD | -20,677,000USD | -9,223,000USD | -11,106,000USD |
| Capital Expenditures | -10,000USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Free Cash Flow | -8,742,000USD | -6,456,000USD | -5,316,000USD | -8,828,000USD | -12,727,000USD | -20,677,000USD | -9,223,000USD | -11,106,000USD |
| Total Cashflows From Investing Activities | -10,000USD | — | — | — | — | — | — | — |
| Net Borrowings | 14,146,000USD | -841,000USD | -405,000USD | -406,000USD | -405,000USD | -406,000USD | -405,000USD | — |
| Total Cash From Financing Activities | 13,916,000USD | 44,694,000USD | -402,000USD | -400,000USD | -411,000USD | -625,000USD | -405,000USD | -365,000USD |
| Change In Cash | 5,174,000USD | 38,273,000USD | -5,718,000USD | -9,228,000USD | -13,138,000USD | -21,302,000USD | -9,628,000USD | -11,471,000USD |
| Begin Period Cash Flow | 48,906,000USD | 10,669,000USD | 16,387,000USD | 25,650,000USD | 38,788,000USD | 60,090,000USD | 69,718,000USD | 81,154,000USD |
| End Period Cash Flow | 54,080,000USD | 48,942,000USD | 10,669,000USD | 16,422,000USD | 25,650,000USD | 38,788,000USD | 60,090,000USD | 69,683,000USD |
| Other Cashflows From Financing Activities | -230,000USD | -6,589,000USD | -402,000USD | 6,000USD | -6,000USD | — | — | -11,000USD |
| Sale Purchase Of Stock | — | 25,000USD | 3,000USD | — | — | — | — | -11,000USD |
| Unclassified Financing Cash Flow | — | 52,099,000USD | — | — | — | — | — | — |
| Investments | — | — | — | — | — | 0USD | 0USD | 0USD |
| Issuance Of Capital Stock | — | — | — | — | — | 0USD | 0USD | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -38,966,000USD | -53,036,000USD | -47,919,000USD | -46,180,000USD | -42,292,000USD | -29,539,000USD | -13,088,000USD | -9,858,000USD |
| Depreciation | 21,000USD | 46,000USD | 70,000USD | 429,000USD | 68,000USD | 36,000USD | 12,000USD | 1,000USD |
| Stock Based Compensation | 2,574,000USD | 5,348,000USD | 4,622,000USD | 3,631,000USD | 3,958,000USD | 755,000USD | 196,000USD | 101,000USD |
| Other Non Cash Items | 3,768,000USD | 249,000USD | -404,000USD | 2,936,000USD | 434,000USD | 66,000USD | 446,000USD | -1,594,000USD |
| Change In Working Capital | -724,000USD | -8,571,000USD | 10,356,000USD | 1,132,000USD | 1,955,000USD | 1,163,000USD | 263,000USD | 1,186,000USD |
| Total Cash From Operating Activities | -33,327,000USD | -55,964,000USD | -33,275,000USD | -41,683,000USD | -35,877,000USD | -27,519,000USD | -12,617,000USD | -8,570,000USD |
| Capital Expenditures | 0USD | 0USD | -7,000USD | -8,000USD | -93,000USD | -74,000USD | -4,000USD | -4,000USD |
| Free Cash Flow | -33,327,000USD | -55,964,000USD | -33,282,000USD | -41,691,000USD | -35,970,000USD | -27,593,000USD | -12,621,000USD | -8,570,000USD |
| Net Borrowings | -2,057,000USD | -1,622,000USD | -1,622,000USD | 0USD | 230,000USD | 230,000USD | 4,500,000USD | 4,500,000USD |
| Total Cash From Financing Activities | 43,481,000USD | -1,622,000USD | 49,140,000USD | -241,000USD | 643,000USD | 181,035,000USD | 12,433,000USD | 12,433,000USD |
| Sale Purchase Of Stock | 25,000USD | 66,000USD | -311,000USD | -40,000USD | 134,000USD | 93,402,000USD | — | — |
| Issuance Of Capital Stock | 50,000,000USD | 0USD | 53,616,000USD | 0USD | 96,255,000USD | 183,888,000USD | 7,941,000USD | 0USD |
| Change In Cash | 10,154,000USD | -57,586,000USD | 71,642,000USD | -18,045,000USD | -114,402,000USD | 153,442,000USD | -188,000USD | -8,570,000USD |
| Begin Period Cash Flow | 38,788,000USD | 96,339,000USD | 24,732,000USD | 42,748,000USD | 157,366,000USD | 3,924,000USD | 4,112,000USD | 12,682,000USD |
| End Period Cash Flow | 48,942,000USD | 38,753,000USD | 96,374,000USD | 24,703,000USD | 42,964,000USD | 157,366,000USD | 3,924,000USD | 4,112,000USD |
| Other Cashflows From Financing Activities | -4,532,000USD | -246,000USD | -2,854,000USD | -40,000USD | 423,000USD | 87,684,000USD | 7,941,000USD | -8,000USD |
| Unclassified Financing Cash Flow | 50,045,000USD | — | 54,096,000USD | — | — | — | -7,949,000USD | 7,941,000USD |
| Investments | — | 0USD | 55,777,000USD | 23,700,000USD | -79,075,000USD | -74,000USD | -4,000USD | -79,075,000USD |
| Total Cashflows From Investing Activities | — | — | 55,777,000USD | 23,692,000USD | -79,168,000USD | -74,000USD | -4,000USD | -4,000USD |
| Dividends Paid | — | — | -169,000USD | — | -423,000USD | — | — | — |
| Change To Liabilities | — | — | — | 1,859,000USD | 1,149,000USD | 3,733,000USD | -226,000USD | 1,697,000USD |
| Cash And Cash Equivalents Changes | — | — | — | -18,232,000USD | — | 153,442,000USD | — | — |
| Other Cashflows From Investing Activities | — | — | — | 23,700,000USD | -121,000USD | — | — | — |
| Unclassified Operating Cash Flow | — | — | — | -3,631,000USD | — | — | — | 1,594,000USD |
| Unclassified Investing Cash Flow | — | — | — | -23,700,000USD | — | — | — | 79,075,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.